Pfizer captures Warner at last

Pfizer and Warner-Lambert ended their bitter takeover battle yesterday when Pfizer agreed to raise its bid to $90bn in stock, reports The Times.

Warner-Lambert's board accepted the new bid, a 10% increase on the sum originally proposed, even though it means Lodewijk de Vink, the Warner-Lambert chairman and chief executive, will lose his job.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump